296 related articles for article (PubMed ID: 25578395)
1. Galectin-1 and galectin-3: plausible tumour markers for oral squamous cell carcinoma and suitable targets for screening high-risk population.
Aggarwal S; Sharma SC; Das SN
Clin Chim Acta; 2015 Mar; 442():13-21. PubMed ID: 25578395
[TBL] [Abstract][Full Text] [Related]
2. Expression of vascular endothelial growth factor (VEGF) in patients with oral squamous cell carcinoma and its clinical significance.
Aggarwal S; Devaraja K; Sharma SC; Das SN
Clin Chim Acta; 2014 Sep; 436():35-40. PubMed ID: 24833243
[TBL] [Abstract][Full Text] [Related]
3. [Expression of galectin-1 in carcinogenesis of oral mucosal epithelium].
Wei KJ; Pan HY; Yang X; Zhong LP; Ye DX; Zhang ZY
Zhonghua Kou Qiang Yi Xue Za Zhi; 2011 Sep; 46(9):524-7. PubMed ID: 22177353
[TBL] [Abstract][Full Text] [Related]
4. Galectin-9 as an important marker in the differential diagnosis between oral squamous cell carcinoma, oral leukoplakia and oral lichen planus.
Muniz JM; Bibiano Borges CR; Beghini M; de Araújo MS; Miranda Alves P; de Lima LM; Pereira SA; Nogueira RD; Napimoga MH; Rodrigues V; Rodrigues DB
Immunobiology; 2015 Aug; 220(8):1006-11. PubMed ID: 25956455
[TBL] [Abstract][Full Text] [Related]
5. Detection of serum Cyfra 21-1 in patients with primary oral squamous cell carcinoma.
Zhong LP; Zhu HG; Zhang CP; Chen WT; Zhang ZY
Int J Oral Maxillofac Surg; 2007 Mar; 36(3):230-4. PubMed ID: 16965897
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of galectin-1 is associated with human oral squamous cell carcinoma development.
Ding YM; Dong JH; Chen LL; Zhang HD
Oncol Rep; 2009 Apr; 21(4):983-7. PubMed ID: 19287997
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of galectin-1 at the tumor invasion front is associated with poor prognosis in early-stage oral squamous cell carcinoma.
Chiang WF; Liu SY; Fang LY; Lin CN; Wu MH; Chen YC; Chen YL; Jin YT
Oral Oncol; 2008 Apr; 44(4):325-34. PubMed ID: 17588803
[TBL] [Abstract][Full Text] [Related]
8. GDF 15 as an anti-apoptotic, diagnostic and prognostic marker in oral squamous cell carcinoma.
Schiegnitz E; Kämmerer PW; Koch FP; Krüger M; Berres M; Al-Nawas B
Oral Oncol; 2012 Jul; 48(7):608-14. PubMed ID: 22341306
[TBL] [Abstract][Full Text] [Related]
9. Prognostic cytokine markers in peripheral blood for oral cavity squamous cell carcinoma identified by multiplexed immunobead-based profiling.
Chang KP; Chang YT; Liao CT; Yen TC; Chen IH; Chang YL; Liu YL; Chang YS; Yu JS; Wu CC
Clin Chim Acta; 2011 May; 412(11-12):980-7. PubMed ID: 21315702
[TBL] [Abstract][Full Text] [Related]
10. Circulating levels of vascular endothelial growth factor in patients with oral squamous cell carcinoma.
Shang ZJ; Li JR; Li ZB
Int J Oral Maxillofac Surg; 2002 Oct; 31(5):495-8. PubMed ID: 12418564
[TBL] [Abstract][Full Text] [Related]
11. The determination of the levels of circulating galectin-1 and -3 in HNSCC patients could be used to monitor tumor progression and/or responses to therapy.
Saussez S; Lorfevre F; Lequeux T; Laurent G; Chantrain G; Vertongen F; Toubeau G; Decaestecker C; Kiss R
Oral Oncol; 2008 Jan; 44(1):86-93. PubMed ID: 17350328
[TBL] [Abstract][Full Text] [Related]
12. Elevated Serum Gas6 Is a Novel Prognostic Biomarker in Patients with Oral Squamous Cell Carcinoma.
Jiang T; Liu G; Wang L; Liu H
PLoS One; 2015; 10(7):e0133940. PubMed ID: 26207647
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of chemokine (C-X-C motif) ligand 9 (CXCL9) are associated with tumor progression and treatment outcome in patients with oral cavity squamous cell carcinoma.
Chang KP; Wu CC; Fang KH; Tsai CY; Chang YL; Liu SC; Kao HK
Oral Oncol; 2013 Aug; 49(8):802-7. PubMed ID: 23769451
[TBL] [Abstract][Full Text] [Related]
14. Elevated level of serum growth differentiation factor 15 is associated with oral leukoplakia and oral squamous cell carcinoma.
Yang CZ; Ma J; Luo QQ; Neskey DM; Zhu DW; Liu Y; Myers JN; Zhang CP; Zhang ZY; Zhong LP
J Oral Pathol Med; 2014 Jan; 43(1):28-34. PubMed ID: 23710769
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
16. Cytokines and tumor markers in potentially malignant disorders and oral squamous cell carcinoma: a pilot study.
Czerninski R; Basile JR; Kartin-Gabay T; Laviv A; Barak V
Oral Dis; 2014 Jul; 20(5):477-81. PubMed ID: 23859102
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of Annexin A2 in oral squamous cell carcinoma.
Zhong LP; Wei KJ; Yang X; Zhang L; Zhou XJ; Pan HY; Li J; Chen WT; Zhang ZY
Arch Oral Biol; 2009 Jan; 54(1):17-25. PubMed ID: 18822406
[TBL] [Abstract][Full Text] [Related]
18. Repression of G protein-coupled receptor family C group 5 member A is associated with pathologic differentiation grade of oral squamous cell carcinoma.
Liu SL; Zhong SS; Ye DX; Chen WT; Zhang ZY; Deng J
J Oral Pathol Med; 2013 Nov; 42(10):761-8. PubMed ID: 23651229
[TBL] [Abstract][Full Text] [Related]
19. Elevated serum levels of a c-erbB-2 oncogene product in oral squamous cell carcinoma patients.
Chen CH; Lin YS; Lin CC; Yang YH; Ho YP; Tsai CC
J Oral Pathol Med; 2004 Nov; 33(10):589-94. PubMed ID: 15482324
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma.
St John MA; Li Y; Zhou X; Denny P; Ho CM; Montemagno C; Shi W; Qi F; Wu B; Sinha U; Jordan R; Wolinsky L; Park NH; Liu H; Abemayor E; Wong DT
Arch Otolaryngol Head Neck Surg; 2004 Aug; 130(8):929-35. PubMed ID: 15313862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]